Myeloid cell interactions with T cells in atherosclerosis
Myeloid cell interactions with T cells in atherosclerosis
批准号:
8499418
负责人:
Klaus F. Ley
金额:
$43.3万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-07-01 至 2017-05-31
关键词:
AcuteAddressAntigen PresentationAntigen-Presenting CellsAntigensAortaApolipoprotein EApolipoproteins BArterial Fatty StreakArteriesAtherosclerosisBehaviorBlood ClotBlood coagulationBromodeoxyuridineCD4 Positive T LymphocytesCardiovascular systemCell CommunicationCell physiologyCellsCholesterolDendritic CellsDetectionDiseaseDsRedEnvironmentEpitopesEventExcisionFlow CytometryFoam CellsFutureGenesGenomeGoalsHistologyImageImmune responseImmune systemImmunofluorescence ImmunologicImmunohistochemistryIn VitroInflammationInflammatoryInterferonsInterleukin-17KnowledgeLeadLesionLeukocytesLifeLipidsLow-Density LipoproteinsMatrix MetalloproteinasesMethodsMicroscopyMouse StrainsMusMyelogenousMyeloid CellsMyocardial InfarctionNecrosisOvalbuminPeptidesPhenotypePlatelet Factor 4PreventionProcessProductionProteinsPublishingReporterReportingResearchRuptureShoulderSourceStaining methodStainsStrokeT-Cell ProliferationT-Cell ReceptorT-LymphocyteTNF geneTechniquesTestingThrombosisThymus GlandTissuesTransgenic MiceTunica AdventitiaVaccinatedautoreactive T cellcellular imagingcytokinedrug developmentexperiencegene therapyhypercholesterolemiaimmunological synapseintima mediamacrophagemonocyteneutralizing antibodyperipheral toleranceuptakevascular inflammation
中文摘要
描述(由申请人提供):我们假设不同的髓系细胞亚群在动脉粥样硬化中具有不同和重叠的功能。在这里,我们建议测试哪些子集负责炎症细胞因子的产生,抗原呈递和泡沫细胞形成,以及这些过程是如何由血小板因子4(Pf 4,也称为CXCL 4)调节。巨噬细胞积聚引发脂肪条纹的形成,其最终发展成动脉粥样硬化病变。巨噬细胞也与易损斑块密切相关,易损斑块破裂会引发主要不良心血管事件(MACE)。巨噬细胞和DC是抗原呈递细胞(APC),其与T细胞相互作用,放大炎症。CD 4 T细胞与APC的相互作用在多光子显微镜中是明显的:T细胞在形成免疫突触时暂停。CXCL 4是Pf 4基因的产物,是促动脉粥样硬化的,并显著改变巨噬细胞表型。为了研究APC的功能,泡沫细胞的形成,抗原呈递和Pf 4对这些过程的影响,我们建议将联合收割机新开发的多光子活细胞成像的主动脉壁流式细胞术,免疫荧光和组织学。具体目标1是在GFP标记的Apoe-/-小鼠中使用主动脉壁流式细胞术和多光子活细胞成像来测试哪些髓样细胞亚群成为主动脉壁中的泡沫细胞。我们已经产生了LysMGFP Apoe-/-、Cx 3cr 1GFP Apoe-/-和CD 11 cYFP Apoe-/-小鼠。在这些小鼠品系中的每一种中,骨髓细胞的不同子集是绿色(或黄色)荧光的。具体目标2是测试T细胞与巨噬细胞和树突状细胞的相互作用对动脉粥样硬化的影响。来源于OTII转基因小鼠的T细胞表达识别卵清蛋白肽的单克隆TCR。从dsRed Apoe-/-小鼠中分离多克隆T细胞,其中一些对“动脉粥样硬化抗原”具有特异性。将这些T细胞转移到LysMGFP Apoe-/-、Cx 3cr 1GFP Apoe-/-和CD 11 cYFP Apoe-/-小鼠的骨髓中,以测试它们与APC的相互作用,预期APC诱导T细胞增殖(BrdU)、极化(干扰素-γ、IL-17 A)和泡沫细胞形成(oxLDL摄取)。具体目的3是研究血小板第4因子对泡沫细胞形成和功能的影响。PF 4是巨噬细胞表型的强调节剂,在体外促进M4表型。据报道,Pf 4-/-Apoe-/-小鼠出现较小的动脉粥样硬化病变。为了解决可能的机制,我们建议将Pf 4-/-Apoe-/-小鼠与我们的荧光报告小鼠杂交,以观察这些小鼠中骨髓亚群组成、表型和行为的变化。当这项研究完成时,我们将知道哪些巨噬细胞亚群成为泡沫细胞,它们在生产性免疫反应中与T细胞相互作用,引发再刺激,增殖和细胞因子产生,以及PF 4如何影响这两个过程。PF 4或其他分子的研究可能会成为预防或治疗动脉粥样硬化及其并发症的目标。
英文摘要
DESCRIPTION (provided by applicant): We hypothesize that different subsets of myeloid cells have distinct and overlapping functions in atherosclerosis. Here, we propose to test which subsets are responsible for inflammatory cytokine production, antigen presentation, and foam cell formation, and how these processes are modulated by platelet factor 4 (Pf4, also known as CXCL4). Macrophage accumulation initiates the formation of fatty streaks, which eventually develop into atherosclerotic lesions. Macrophages are also critically involved in vulnerable plaque, whose rupture triggers major adverse cardiovascular events (MACE). Macrophages and DCs are antigen- presenting cells (APCs) that interact with T cells, amplifying inflammation. CD4 T cell interaction with APCs is evident in multiphoton microscopy: the T cells pause when they form an immunological synapse. CXCL4, the product of the Pf4 gene, is pro-atherogenic and drastically alters macrophage phenotype. To investigate APC functions, foam cell formation, antigen presentation and the impact of Pf4 on these processes, we propose to combine newly developed multiphoton live cell imaging of the aortic wall with flow cytometry, immunofluorescence and histology. Specific aim 1 is to test which subsets of myeloid cells become foam cells in the aortic wall, using aortic wall flow cytometry and multiphoton live cell imaging in GFP-tagged Apoe-/- mice. We have generated LysMGFP Apoe-/-, Cx3cr1GFP Apoe-/- and CD11cYFP Apoe-/- mice. In each of these mouse strains, different subsets of myeloid cells are green (or yellow) fluorescent. Specific aim 2 is to test the effects of T cell interactios with macrophages and dendritic cells on atherosclerosis. T cells derived from OTII transgenic mice express a monoclonal TCR that recognizes an ovalbumin peptide. Polyclonal T cells, some of which are specific to "atherosclerosis antigens", are isolated from dsRed Apoe-/- mice. These T cells are transferred to aortas of LysMGFP Apoe-/-, Cx3cr1GFP Apoe-/- and CD11cYFP Apoe-/- mice to test their interactions with APCs, which are expected to induce T cell proliferation (BrdU), polarization (interferon-¿, IL-17A) and foam cell formation (oxLDL uptake). Specific aim 3 is to investigate the effect of platelet factor 4 on foam cell formation an function. PF4 is a strong modulator of macrophage phenotype, promoting the M4 phenotype in vitro. Pf4-/-Apoe-/- mice have been reported to develop smaller atherosclerotic lesions. To address possible mechanisms, we propose to cross Pf4-/-Apoe-/- mice with our fluorescent reporter mice to visualize changes in myeloid subset composition, phenotype and behavior in these mice. When this research is complete, we will know which macrophage subset(s) become foam cells, which interact with T cells in a productive immune response to trigger re-stimulation, proliferation and cytokine production, and how PF4 influences both processes. PF4 or other molecules investigated here may emerge as targets for prevention or therapy of atherosclerosis and its complications.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanism of kindlin-3-dependent integrin activation
-
批准号:10676897
-
项目类别:
-
资助金额:$54.92万
-
财政年份:2020
-
负责人:Klaus F. Ley
-
依托单位:
Mechanism of kindlin-3-dependent integrin activation
-
批准号:10229369
-
项目类别:
-
资助金额:$54.93万
-
财政年份:2020
-
负责人:Klaus F. Ley
-
依托单位:
Vascular macrophages and T cells in atherosclerosis
-
批准号:10112954
-
项目类别:
-
资助金额:$90.72万
-
财政年份:2019
-
负责人:Klaus F. Ley
-
依托单位:
Vascular macrophages and T cells in atherosclerosis
-
批准号:10369710
-
项目类别:
-
资助金额:$58.9万
-
财政年份:2019
-
负责人:Klaus F. Ley
-
依托单位:
Vascular macrophages and T cells in atherosclerosis
-
批准号:9895858
-
项目类别:
-
资助金额:$90.7万
-
财政年份:2019
-
负责人:Klaus F. Ley
-
依托单位:
Vascular macrophages and T cells in atherosclerosis
-
批准号:10623034
-
项目类别:
-
资助金额:$31.83万
-
财政年份:2019
-
负责人:Klaus F. Ley
-
依托单位:
Vascular macrophages and T cells in atherosclerosis
-
批准号:10565907
-
项目类别:
-
资助金额:$76.97万
-
财政年份:2019
-
负责人:Klaus F. Ley
-
依托单位:
Core E: Cell sorting, CyTOF and RNA-Seq
-
批准号:10188604
-
项目类别:
-
资助金额:$54.45万
-
财政年份:2017
-
负责人:Klaus F. Ley
-
依托单位:
Core B: Single Cell Protein and RNA Sequencing Core
-
批准号:10334092
-
项目类别:
-
资助金额:$5.35万
-
财政年份:2017
-
负责人:Klaus F. Ley
-
依托单位:
Super-resolution confocal microscope
-
批准号:9274885
-
项目类别:
-
资助金额:$56.63万
-
财政年份:2017
-
负责人:Klaus F. Ley
-
依托单位:
ApoB-specific CD4 T cells in mouse and human atherosclerosis
-
批准号:10188608
-
项目类别:
-
资助金额:$38.98万
-
财政年份:2017
-
负责人:Klaus F. Ley
-
依托单位:
Project 4: APOB-specific CD4 and CD8 T cells exacerbate atherosclerosis
-
批准号:10334097
-
项目类别:
-
资助金额:$4.3万
-
财政年份:2017
-
负责人:Klaus F. Ley
-
依托单位:
Vaccination with MHC-II restricted ApoB100 peptides to prevent atherosclerosis
-
批准号:8819012
-
项目类别:
-
资助金额:$45.55万
-
财政年份:2014
-
负责人:Klaus F. Ley
-
依托单位:
Vaccination with MHC-II restricted ApoB100 peptides to prevent atherosclerosis
-
批准号:8966694
-
项目类别:
-
资助金额:$43.63万
-
财政年份:2014
-
负责人:Klaus F. Ley
-
依托单位:
VASCULATA 2013: Vascular Immunology
-
批准号:8597858
-
项目类别:
-
资助金额:$1.25万
-
财政年份:2013
-
负责人:Klaus F. Ley
-
依托单位:
Myeloid cell interactions with T cells in atherosclerosis
-
批准号:8675936
-
项目类别:
-
资助金额:$42.48万
-
财政年份:2012
-
负责人:Klaus F. Ley
-
依托单位:
Myeloid cell interactions in atherosclerosis
-
批准号:9311933
-
项目类别:
-
资助金额:$45.0万
-
财政年份:2012
-
负责人:Klaus F. Ley
-
依托单位:
Myeloid cell interactions with T cells in atherosclerosis
-
批准号:8346057
-
项目类别:
-
资助金额:$56.61万
-
财政年份:2012
-
负责人:Klaus F. Ley
-
依托单位:
Myeloid cell interactions with T cells in atherosclerosis
-
批准号:9065736
-
项目类别:
-
资助金额:$43.35万
-
财政年份:2012
-
负责人:Klaus F. Ley
-
依托单位:
Cell Phenotyping Core
-
批准号:8703257
-
项目类别:
-
资助金额:$10.93万
-
财政年份:2008
-
负责人:Klaus F. Ley
-
依托单位:
海外基金